American Century Companies
IGMS

American Century Companies’s IGM Biosciences IGMS Stock Holding History

American Century Companies’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16,798
Closed -$115K – 2922
2024
Q2 		$115K Sell
16,798
-309
-2% -$2.64K ﹤0.01% 2799
2024
Q1 		$165K Buy
+17,107
New +$198K ﹤0.01% 2792

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies's IGMS Position: Q3 2024 in Review

American Century Companies sold out of IGM Biosciences (IGMS) in Q3 2024, closing a stake of 16,798 shares — an estimated $115K sold.

American Century Companies first reported a position in IGMS in Q1 2024 and held it in 2 quarters. The position peaked at $165K in Q1 2024. 72 funds tracked by Wall St. Rank hold IGMS as of Q3 2024.

  • American Century Companies reported no remaining IGM Biosciences position as of Q3 2024 after selling out during the quarter.
  • American Century Companies sold 16,798 IGM Biosciences shares in Q3 2024, an estimated $115K.
  • American Century Companies first reported a position in IGM Biosciences in Q1 2024 and held it in 2 quarters.
  • American Century Companies's IGM Biosciences position peaked at $165K in Q1 2024.
  • 72 funds tracked by Wall St. Rank held IGM Biosciences as of Q3 2024.

Based on American Century Companies's 13F filing for Q3 2024, filed 12 Nov 2024.